All Pathways
Emergency MedicineEmergency

Upper GI Bleeding Management (ACG 2021)

Upper GI Bleeding Management (ACG 2021): START: Suspected UGIB → Initial Resuscitation → Hemodynamically Stable? → Aggressive Resuscitation → IV PPI The...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    START: Suspected UGIB

    Hematemesis, melena, or coffee-ground emesis

    1. Action

      Initial Resuscitation

      Stabilize before risk stratification

      • 2 large-bore IVs (≥18G)
      • Type and screen/crossmatch
      • CBC, BMP, coags, LFTs
      • NPO status
      • Continuous monitoring
      1. Decision

        Hemodynamically Stable?

        Assess vital signs and perfusion

        • UNSTABLE: SBP <90, HR >100, orthostatic changes, signs of shock
        • STABLE: Normal vitals, no orthostatic changes
        1. Warning

          Aggressive Resuscitation

          Hemodynamic instability

          • Crystalloid bolus
          • Blood transfusion (target Hgb ≥7, or ≥8 if CAD)
          • Consider massive transfusion protocol if ongoing bleeding
          • Correct coagulopathy (FFP if INR >1.5, platelets if <50K)
          • Early GI and surgical consult
          1. Action

            IV PPI Therapy

            Start before endoscopy

            • IV PPI bolus: Pantoprazole 80mg or equivalent
            • Followed by continuous infusion 8mg/hr (for high-risk stigmata)
            • OR intermittent high-dose (80mg q12h) if low-risk stigmata
            • Continue until endoscopy determines risk
            1. Action

              Consider Erythromycin

              Prokinetic before EGD

              • Erythromycin 250mg IV 20-90 min before EGD
              • Improves visualization
              • Reduces need for repeat endoscopy
              • Conditional recommendation
              1. Decision

                EGD Timing

                Based on stability and risk

                • URGENT (<12 hr): Hemodynamically unstable, ongoing bleeding
                • EARLY (12-24 hr): High-risk patients (GBS ≥12, liver disease)
                • STANDARD (<24 hr): All other admitted patients
                1. Action

                  Upper Endoscopy (EGD)

                  Diagnostic and therapeutic

                  • Identify bleeding source
                  • Forrest classification for ulcers
                  • Endoscopic therapy if high-risk stigmata
                  • Combination therapy preferred (epinephrine + thermal/clip)
                  1. Decision

                    Forrest Classification

                    Ulcer stigmata risk

                    • HIGH-RISK (treat): Ia (spurting), Ib (oozing), IIa (visible vessel), IIb (adherent clot)
                    • LOW-RISK (no treatment): IIc (flat spot), III (clean base)
                    1. Action

                      High-Risk Stigmata

                      Endoscopic therapy required

                      • Combination therapy: Epinephrine injection + thermal/clips
                      • High-dose IV PPI infusion x 72 hours post-EGD
                      • NPO initially, advance diet as tolerated
                      • Monitor for rebleeding
                      1. Warning

                        Rebleeding?

                        Signs of recurrent hemorrhage

                        • Hematemesis or melena recurrence
                        • Hemoglobin drop >2g despite transfusion
                        • Hemodynamic instability
                        1. Action

                          Repeat EGD vs IR/Surgery

                          Manage rebleeding

                          • Repeat EGD for second attempt at hemostasis
                          • Interventional radiology (angioembolization) if EGD fails
                          • Surgery if IR unavailable or fails
                        2. Outcome

                          Discharge Planning

                          After successful management

                          • Test and treat H. pylori if ulcer
                          • Review and stop NSAIDs if possible
                          • PPI for 8-12 weeks (longer if on anticoagulation)
                          • GI follow-up
                          • Discuss anticoagulation/antiplatelet resumption with cardiology
                    2. Action

                      Low-Risk Stigmata

                      Medical management

                      • No endoscopic therapy needed for IIc/III
                      • Oral PPI daily
                      • Early feeding (within 24 hr)
                      • Early discharge if stable
        2. Action

          Risk Stratification

          Calculate Glasgow-Blatchford Score (GBS)

          • BUN, Hemoglobin, SBP, HR, Melena, Syncope, Liver disease, Heart failure
          • GBS = 0-1: Very low risk, may consider outpatient management
          • GBS ≥1: Admit for inpatient management
          1. Decision

            GBS 0-1?

            Very low risk patients

            1. Outcome

              Consider Outpatient EGD

              GBS 0-1 may be discharged

              • Oral PPI twice daily
              • EGD within 24-72 hours as outpatient
              • Clear return precautions
              • Reliable patient with good support

Guideline Source

ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address variceal bleeding in detail (separate algorithm)
  • Risk scores should be calculated formally
  • Endoscopy timing varies by local resources
  • PPI dosing may vary by institution
  • Transfusion triggers are general - individualize for comorbidities

Contraindicated Populations

pediatric

Applicable Regions

USEUGlobal

EU: ESGE guidelines are similar, minor differences in PPI dosing

US: ACG is primary US guideline

Version 1Next review: 2028-01-01

Frequently Asked Questions

What is the Upper GI Bleeding Management (ACG 2021)?

The Upper GI Bleeding Management (ACG 2021) is a emergency clinical algorithm for Emergency Medicine. It provides a structured decision tree to guide clinical decision-making, based on ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding.

What guideline is the Upper GI Bleeding Management (ACG 2021) based on?

This algorithm is based on ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding (DOI: 10.14309/ajg.0000000000001529).

What are the limitations of the Upper GI Bleeding Management (ACG 2021)?

Known limitations include: Does not address variceal bleeding in detail (separate algorithm); Risk scores should be calculated formally; Endoscopy timing varies by local resources; PPI dosing may vary by institution; Transfusion triggers are general - individualize for comorbidities. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Upper GI Bleeding Management (ACG 2021) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free